These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

466 related articles for article (PubMed ID: 34680038)

  • 21. Opposite expression patterns of Sonic hedgehog and Indian hedgehog are associated with aberrant methylation status of their promoters in colorectal cancers.
    Fu X; Yang X; Li J; Tian X; Cai J; Zhang Y
    Pathology; 2010; 42(6):553-9. PubMed ID: 20854074
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Metabolic recoding of epigenetics in cancer.
    Wang YP; Lei QY
    Cancer Commun (Lond); 2018 May; 38(1):25. PubMed ID: 29784032
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic Alternations of MicroRNAs and DNA Methylation Contribute to Liver Metastasis of Colorectal Cancer.
    Liu J; Li H; Sun L; Shen S; Zhou Q; Yuan Y; Xing C
    Dig Dis Sci; 2019 Jun; 64(6):1523-1534. PubMed ID: 30604369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. O-GlcNAc signaling in cancer metabolism and epigenetics.
    Singh JP; Zhang K; Wu J; Yang X
    Cancer Lett; 2015 Jan; 356(2 Pt A):244-50. PubMed ID: 24769077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of epigenetics in colorectal cancer.
    Coppedè F
    Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):935-48. PubMed ID: 24871610
    [TBL] [Abstract][Full Text] [Related]  

  • 26. DNA methylation aberrancies delineate clinically distinct subsets of colorectal cancer and provide novel targets for epigenetic therapies.
    Weisenberger DJ; Liang G; Lenz HJ
    Oncogene; 2018 Feb; 37(5):566-577. PubMed ID: 28991233
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revealing the role of epigenetic and post-translational modulations of autophagy proteins in the regulation of autophagy and cancer: a therapeutic approach.
    Chowdhury SG; Karmakar P
    Mol Biol Rep; 2023 Dec; 51(1):3. PubMed ID: 38063905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer.
    Huo M; Zhang J; Huang W; Wang Y
    Front Cell Dev Biol; 2021; 9():793428. PubMed ID: 35004688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of gut microbiota in epigenetic regulation of colorectal Cancer.
    Zhao Y; Wang C; Goel A
    Biochim Biophys Acta Rev Cancer; 2021 Jan; 1875(1):188490. PubMed ID: 33321173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of epigenetics in transformation of inflammation into colorectal cancer.
    Yang ZH; Dang YQ; Ji G
    World J Gastroenterol; 2019 Jun; 25(23):2863-2877. PubMed ID: 31249445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the interplay between metabolism and epigenetics in cancer.
    Montellier E; Gaucher J
    Curr Opin Oncol; 2019 Mar; 31(2):92-99. PubMed ID: 30562315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interplay between Metabolism and Epigenetics: A Nuclear Adaptation to Environmental Changes.
    Etchegaray JP; Mostoslavsky R
    Mol Cell; 2016 Jun; 62(5):695-711. PubMed ID: 27259202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer.
    Tran TQ; Lowman XH; Kong M
    Clin Cancer Res; 2017 Aug; 23(15):4004-4009. PubMed ID: 28404599
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigenetic-based therapy for colorectal cancer: Prospect and involved mechanisms.
    Rezapour S; Hosseinzadeh E; Marofi F; Hassanzadeh A
    J Cell Physiol; 2019 Nov; 234(11):19366-19383. PubMed ID: 31020647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigation of epigenetics in kidney cell biology.
    Li LX; Agborbesong E; Zhang L; Li X
    Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metaboloepigenetics: interrelationships between energy metabolism and epigenetic control of gene expression.
    Donohoe DR; Bultman SJ
    J Cell Physiol; 2012 Sep; 227(9):3169-77. PubMed ID: 22261928
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Distinct epigenetic signatures elucidate enhancer-gene relationships that delineate CIMP and non-CIMP colorectal cancers.
    Chong A; Teo JX; Ban KH
    Oncotarget; 2016 May; 7(19):28027-39. PubMed ID: 27049830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic and epigenetic profiling in early colorectal tumors and prediction of invasive potential in pT1 (early invasive) colorectal cancers.
    Nosho K; Yamamoto H; Takahashi T; Mikami M; Taniguchi H; Miyamoto N; Adachi Y; Arimura Y; Itoh F; Imai K; Shinomura Y
    Carcinogenesis; 2007 Jun; 28(6):1364-70. PubMed ID: 17183069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histone deacetylase inhibitors and epigenetic modifications as a novel strategy in renal cell carcinoma.
    Ramakrishnan S; Pili R
    Cancer J; 2013; 19(4):333-40. PubMed ID: 23867515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetics and cancer metabolism.
    Johnson C; Warmoes MO; Shen X; Locasale JW
    Cancer Lett; 2015 Jan; 356(2 Pt A):309-14. PubMed ID: 24125862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.